Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 133 of 144 pages ‹ First < 131 132 133 134 135 > Last ›
HSL2303
Lehner JP, Meyer F, Juillet Y.
[Communication and transparency concerning risk-benefit analysis in public health: the example of medication]
Therapie. 2001 Jul-Aug;56(4):335-9 2002 Jul-Aug 01; 56:(4):335-9
HSL2503
Health plans keeping drug cost increases in check with programs that promote generics.
Capitation Manag Rep. 2002 July 01; 9:(7):101-3
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12164057
HSL5326
Doolan DF, Bates DW.
Computerized physician order entry systems in hospitals: mandates and incentives.
Health Aff (Millwood) 2002 Jul-Aug 01; 21:(4):180-8
http://content.healthaffairs.org/cgi/reprint/21/4/180
HSL1925
Theroux R.
Bypassing the middleman: a grounded theory of women's self-care for vaginal symptoms.
Health Care Women Int 2002 Jul-Aug; 23:(5):417-31
http://journalsonline.tandf.co.uk/app/home/contribution.asp?wasp=258b145abdcf4aa3aee66667fe129285&referrer=parent&backto=issue,2,10;journal,28,59;linkingpublicationresults,1:101823,1
HSL1967
Quinn RJ, O'Neill C.
Attitudes of general practitioners to their interactions with pharmaceutical companies: a qualitative study.
Ir Med J 2002 Jul-Aug; 95:(7):199-202
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12227525
HSL2250
Klein JE, Fleischman AR.
The private practicing physician-investigator: ethical implications of clinical research in the office setting.
Hastings Cent Rep 2002 Jul-Aug; 32:(4):22-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12362520
HSL2478
Coolidge MP.
Drug samples: friend or foe?
J Drugs Dermatol 2002 Jul; 1:(1):49-52
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12847754
HSL2497
Bennett J, Collins J.
The relationship between physicians and the biomedical industries: advice from the Royal College of Physicians.
Clin Med 2002 Jul-Aug; 2:(4):320-2
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12195858
HSL2452
Hoye S, Hjortdahl P.
New wonder pill!--what do Norwegian newspapers write
2002 Jun 30;122(17):1671-6 2002 June 30; 122:(17):1671-6
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12555610
HSL1692
Redelmeier DA, Cialdini RB.
Problems for clinical judgement: 5. Principles of influence in medical practice
CMAJ 2002 Jun 25; 166:(13):1680-4
http://www.cmaj.ca/cgi/content/full/166/13/1680
HSL17901
Hunter M
UK consumers reject direct advertising to patients by drug industry
BMJ 2002 Jun 15; 324:(7351):1416
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1172194/
HSL19049
Woloshin S, Schwartz LM, Welch HG.
Tobacco money: up in smoke?
Lancet 2002 June 15; 359:(9323):2108-11
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(02)08939-0
HSL2245
Leenen FH.
Conflicts of interest and libel action.
N Engl J Med 2002 Jun 13; 346:(24):1919-20
HSL2470
Drazen JM, Curfman GD.
Financial associations of authors.
N Engl J Med 2002 Jun 13; 346:(24):1901-2
http://content.nejm.org/cgi/content/full/346/24/1901
HSL2473
Detsky A[AU].
Dr Detsky replies
NEJM 2002 Jun 13; 346:(24):1920
HSL17902
Mayor S
Researchers claim clinical trials are reported with misleading statistics
BMJ 2002 Jun 8; 324:(7350):1353
http://www.bmj.com/cgi/content/extract/324/7350/1353/a
HSL19051
Schwartz LM, Woloshin S, Baczek L.
Media coverage of scientific meetings: too much, too soon?
JAMA 2002 June 8; 287:(21):2859-63
http://jama.ama-assn.org/content/287/21/2859.long
HSL1771
Hawkes N.
How to spot a 'misleading' health story
2002 Jun 5
HSL17903
Woloshin S, Schwartz LM.
Press releases: translating research into news.
JAMA 2002 Jun 5; 287:(21):2856-8
http://jama.ama-assn.org/cgi/content/full/287/21/2856
HSL19810
Rochon PA, Bero LA, Bay AM, Gold JL, Dergal JM, Binns MA, Streiner DL, Gurwitz JH
Comparison of Review Articles Published in Peer-Reviewed and Throwaway Journals
JAMA 2002 Jun 5; 287:(21):2853-2856
http://jama.ama-assn.org/content/287/21/2853.full
HSL153
Stevenson K.
Health Forum: Out of the game: A frustrated psychiatrist abandons her practice to get out from under 'evaluating and medicating'
Post Gazette (Pittsburgh) 2002 Jun 4
HSL17905
Redfearn S
Journal: Drug Sales Based on 'Seriously Biased' Data
The Washington Post 2002 Jun 4
http://www.washingtonpost.com/wp-dyn/articles/A54319-2002Jun3.html
HSL5403
Orlowski JP, Christensen JA.
The potentially coercive nature of some clinical research trial acronyms.
Chest 2002 Jun 01; 121:(6):2023-8
http://www.chestjournal.org/cgi/content/full/121/6/2023
HSL17906
Moynihan R
Celebrity selling
BMJ 2002 Jun 1; 324:(7349):1342
http://www.bmj.com/cgi/content/citation/324/7349/1342?HITS=10&hits=10&stored;_search=&author1=Moynihan%2C%2BR&maxtoshow;=&FIRSTINDEX=0&resourcetype=1,2,3,4,10&searchid=1023661467365_9984&RESULTFORMAT;=
HSL1963
Ripamonti C, Bianchi M.
The use of methadone for cancer pain.
Hematol Oncol Clin North Am 2002 Jun; 16:(3):543-55
HSL1969
Pinkus RL.
From Lydia Pinkham to Bob Dole: what the changing face of direct-to-consumer drug advertising reveals about the professionalism of medicine.
Kennedy Inst Ethics J 2002 Jun; 12:(2):141-58
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=12476915
HSL10434
Tackling antibiotic waste.
Prescrire Int 2002 Jun; 11:(59):93
HSL10435
Missing data.
Prescrire Int 2002 Jun; 11:(59):92
HSL15304
Denig P, Witteman CL, Schouten HW.
Scope and nature of prescribing decisions made by general practitioners.
Qual Saf Health Care 2002 Jun; 11:(2):137-43
http://qshc.bmj.com/cgi/content/full/11/2/137
HSL1769
Vedantam S.
Industry Role in Medical Meeting Decried
Washington Post Staff Writer 2002 May 26
HSL2484
Charatan F.
Doctor sues company over unethical marketing.
BMJ 2002 May 25; 324:(7348):1234
http://bmj.com/cgi/content/full/324/7348/1234/b
HSL17907
How Whistleblowing cost one doctor £550,000
BMJ 2002 May 25;
http://www.bmj.com/cgi/content/extract/324/7348/1240
HSL17913
Burton B
Australia turns to drug company representatives to cut prescribing
BMJ 2002 May 25; 324:(7348):1234
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1123208/
HSL17914
Ed.
Europe on the brink of direct-to-consumer drug advertising
Lancet 2002 May 18; 359:(9319):1709
http://www.lancet.com/journals/lancet/article/PIIS0140-6736(02)08637-3/fulltext
HSL1768
Petersen M.
Suit Says Company Promoted Drug in Exam Rooms
The New York Times 2002 May 15
http://www.ncbi.nlm.nih.gov/pubmed/12056438
HSL1767
Health Fact Sheet 1 – Securing the future of the Pharmaceutical Benefits Scheme
2002 May 14
HSL17912
Ferris LE.
Industry-sponsored pharmaceutical trials and research ethics boards: are they cloaked in too much secrecy?
CMAJ 2002 May 14; 166:(10):1279-80
http://www.cmaj.ca/cgi/content/full/166/10/1279
HSL1838
Romano M.
Student rally Med school attendees write ethics code on drug firms.
Mod Healthc 2002 May 13; 32:(19):24,
HSL17910
Spurgeon D
Doctors accept $50 a time to listen to drug representatives
BMJ 2002 May 11; 324:(7346):1113
http://www.bmj.com/cgi/content/extract/324/7346/1113/a
HSL17393
Silverman E
Drug maker cancels tony N.Y. 'lecture'
The Star Ledger 2002 May 10
HSL17908
Gottlieb S
Drug companies maintain 'astounding' profits.
BMJ 2002 May 4; 324:(7345):1054
http://www.bmj.com/cgi/content/extract/324/7345/1054/b
HSL17916
The Science of Persuasion
The Economist 2002 May 2
http://www.economist.com/displaystory.cfm?story_id=1109515
HSL3700
Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH.
Timing of new black box warnings and withdrawals for prescription medications.
JAMA 2002 May 1; 287:(17):2215-20
http://jama.ama-assn.org/cgi/content/full/287/17/2215
HSL5655
Herlihyj , Gandy , J
Causation and explanation
The Psychologist 2002 May 1; 15:(5):248-251
HSL17911
Temple RJ, Himmel MH.
Safety of newly approved drugs: implications for prescribing.
JAMA 2002 May 1; 287:(17):2273-5
http://jama.ama-assn.org/cgi/pmidlookup?view=long&pmid=11980528
HSL1614
Petty RE, Brinol P, Tormala ZL.
Thought confidence as a determinant of persuasion: the self-validation hypothesis.
J Pers Soc Psychol 2002 May; 82:(5):722-41
http://content.apa.org/journals/psp/82/5/722
HSL1973
Panush RS.
Not for sale, not even for rent: just say no. Thoughts about the American College of Rheumatology adopting a code of ethics.
J Rheumatol 2002 May; 29:(5):1049-57
http://www.jrheum.com/subscribers/02/05/1049.html
HSL5291
Beckwith H.
Selling the Invisible : A Field Guide to Modern Marketing
New York: Texere 2002
HSL17909
Trotter G.
Why were the benefits of tPA exaggerated?
West J Med 2002 May; 176:(3):194-7
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1071715/?tool=pubmed
HSL1766
Mallaby S.
Arthur Andersens of Medicine
Washington Post 2002 Apr 28
http://news.google.com/newspapers?nid=1821&dat=20020504&id=JjUtAAAAIBAJ&sjid=Hr4EAAAAIBAJ&pg=1161,1277740
HSL1770
Pharma John
Drugmarketing in the 21st Century
2002 Apr 27
HSL1765
Medicines in Europe Forum, Medicines policy projects: A threat to consumers and patients
e-drug 2002 Apr 26
http://www.essentialdrugs.org/edrug/archive/200204/msg00108.php
HSL1968
Pope John Paul II.
The profit motive behind too much medical research.
Origins 2002 Apr 25; 31:(45):754-5
HSL1763
Hensley S.
New Rules Will Push Drug Firms To New Tactics in Wooing Doctors
The Wall Street Journal 2002 Apr 23
http://online.wsj.com/article/SB101950641556616040.html?mod=googlewsj
HSL1764
Kolata G.
In Public Health, Definitive Data Can Be Elusive
New York Times 2002 Apr 23
http://www.nytimes.com/2002/04/23/science/in-public-health-definitive-data-can-be-elusive.html?pagewanted=1
HSL1762
Brubaker B.
Drug Industry Adopts Guidelines on Giveaways to Doctors
Washington Post 2002 Apr 20
http://www.washingtonpost.com/wp-dyn/articles/A18058-2002Apr19.html
HSL2084
Young JM, Glasziou P, Ward JE.
General practitioners' self ratings of skills in evidence based medicine: validation study.
BMJ 2002 Apr 20; 324:(7343):950-1
http://bmj.bmjjournals.com/cgi/content/full/324/7343/950
HSL2475
Dal-Pizzol F.
Drug advertisements in less-developed countries.
Lancet 2002 Apr 20; 359:(9315):1439-40
http://linkinghub.elsevier.com/retrieve/pii/S0140673602083836
HSL1757
Grady D.
Scientists Question Hormone Therapies for Menopause Ills
New York Times 2002 Apr 19
http://www.nytimes.com/2002/04/18/us/scientists-question-hormone-therapies-for-menopause-ills.html?pagewanted=1
HSL1758
Pollack A
Despite Billions for Discoveries, Pipeline of Drugs Is Far From Full
The New York Times 2002 Apr 19
http://www.nytimes.com/2002/04/19/business/despite-billions-for-discoveries-pipeline-of-drugs-is-far-from-full.html?pagewanted=1
HSL1759
Agovino T.
Drug industry tightens guidelines on marketing to doctors
AP Business Writer 2002 Apr 19
HSL1760
Clarke T.
Drugmakers Plan New Rules to Cut Perks for Doctors
Reuters 2002 Apr 19
HSL1761
Hensley S.
Drug industry curbs 'dine and dash' marketing
The Wall Street Journal 2002 Apr 19
HSL1755
Parker-Pope T.
Latest Craze in Coupon-Clipping: Free Trials for Prescription Drugs
Wall Street Journal 2002 Apr 16
HSL1756
New Findings on Physicians' Views of Doctors and Prescription Drugs
The Henry J. Kaiser Family Foundation 2002 Apr 16
HSL1754
Jopson D.
Vaccine for Aborigines spurned by drug makers
Sydney Morning Herald 2002 Apr 15
HSL17382
THE 2002 FORTUNE 500 report on the Pharmaceutical Industry
2002 Apr 15
HSL1752
Robotham J.
Illness exaggerated as companies strive to sell more drugs
Sydney Morning Herald 2002 Apr 13
HSL1753
Metherall M.
Drug deals
Sydney Morning Herald 2002 Apr 13
HSL1980
Moynihan R.
Drug firms hype disease as sales ploy, industry chief claims.
BMJ 2002 Apr 13; 324:(7342):867
http://bmj.bmjjournals.com/cgi/content/full/324/7342/867
HSL2024
Mintzes B.
For and against: Direct to consumer advertising is medicalising normal human experience: For.
BMJ 2002 Apr 13; 324:(7342):908-9
http://bmj.bmjjournals.com/cgi/content/full/324/7342/908
HSL2092
Moynihan R, Heath I, Henry D.
Selling sickness: the pharmaceutical industry and disease mongering.
BMJ 2002 Apr 13; 324:(7342):886-91
http://bmj.bmjjournals.com/cgi/content/full/324/7342/886
HSL2491
Bonaccorso S, Sturchio J.
Direct to consumer advertising is medicalising normal human experience: Against
BMJ 2002 Apr 13; 324:(7342):910-911
http://bmj.com/cgi/content/full/324/7342/910
HSL7763
Bonaccorso SN, Sturchio JL.
For and against: Direct to consumer advertising is medicalising normal human experience: Against.
BMJ 2002 Apr 13; 324:(7342):910-1
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=11950746
HSL1750
O'Malley N.
Ad agencies liable if they mislead
Sydney Morning Herald 2002 Apr 12
HSL1751
Denoon D.
Are Drug Companies Making Us Sick?
WebMD Medical News 2002 Apr 12
HSL1747
Burne J.
The drug pushers
Guardian 2002 Apr 11
HSL1748
Winslow R.
Black Doctors See Drug Ads As Beneficial for Minorities
The Wall Street Journal 2002 Apr 11
HSL1749
Petersen M.
Methods Used for Marketing Arthritis Drug Are Under Fire
New York Times 2002 Apr 11
http://www.nytimes.com/2002/04/11/business/methods-used-for-marketing-arthritis-drug-are-under-fire.html?pagewanted=1
HSL19050
Woloshin S, Schwartz LM, Welch HG.
Risk charts: putting cancer in context.
J Natl Cancer Inst 2002 April 11; 94:(11):799-804
http://jnci.oxfordjournals.org/content/94/11/799.long
HSL1746
Metherell M.
Budget to force up drug prices
Sydney Morning Herald 2002 Apr 10
http://www.smh.com.au/articles/2002/04/09/1018333354729.html
HSL11649
Kolata G.
Test Proves Fruitless, Fueling New Debate on Cancer Screening
New York Times 2002 Apr 9
http://www.nytimes.com/2002/04/09/science/09CANC.html?pagewanted=1&ei=5070&en=dfb7e38ab6a9ca5c&ex=1191729600
HSL17384
Stein C
A colorful strategy
The Boston Globe 2002 Apr 9
HSL1745
Giombetti R.
Suicide Science - Dr. David Dunner: Paxil's Friendly Ghostwriter?
www.counterpunch.org 2002 Apr 8
HSL17383
Wilton K
Part 1: Union urges Quebec action to cut pharmaceutical costs
Montreal Gazette 2002 Apr 8
HSL2468
The Editor
Just how tainted has medicine become.
Lancet 2002 April 6; 359:(9313):1167
http://linkinghub.elsevier.com/retrieve/pii/S0140673602081989
HSL1743
Robotham J.
Big business, bad medicine cloud our epidemic of the blues
The Sydney Morning Herald 2002 Apr 3
HSL1744
Keon J.
Prescription medicine: "Think of the needs of tax payers before those of the multinationals"
Canadian Drug Manufacturers Association 2002 Apr 3
HSL2486
Cassels A.
Push for consumer drug ads gets cool reception in Europe.
CMAJ 2002 Apr 2; 166:(7):946
http://www.cmaj.ca/cgi/pmidlookup?view=long&pmid=11949998
HSL1742
Toner R.
Rising Drug Costs a Powerful Issue for National and State Politicians
New York Times 2002 Apr 1
http://www.nytimes.com/2002/04/01/us/rising-drug-costs-a-powerful-issue-for-national-and-state-politicians.html?pagewanted=1
HSL3812
Edmonds JP, Day RO, Bertouch JV.
The road to consensus: considerations for the safe use and prescribing of COX-2-specific inhibitors.
Med J Aust 2002 Apr 1; 176:(7):332-4
http://www.mja.com.au/public/issues/176_07_010402/edm10003_fm.html
HSL5849
Toop L, Richards D.
DTCA in New Zealand: the challenge of finding an acceptable balance
Br J Gen Pract. 2002 Apr 1; 52:(477):341
HSL17978
Van der Weyden MB.
Clinical practice guidelines: time to move the debate from the how to the who.
Med J Aust 2002 Apr 1; 176:(7):304-5
http://www.mja.com.au/public/issues/176_07_010402/martineditorial_fm.html
HSL1921
Viale PH.
Direct-to-consumer advertising of prescription medications: implications for patients with cancer.
Oncol Nurs Forum 2002 Apr; 29:(3):505-13
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11979283
HSL2025
Miller FG, Shorr AF.
Ethical assessment of industry-sponsored clinical trials: a case analysis.
Chest 2002 Apr; 121:(4):1337-42
http://www.chestjournal.org/cgi/content/full/121/4/1337
HSL2502
[No authors listed].
Roche turns to DM to boost patient compliance with its weight loss drug.
Dis Manag Advis 2002 Apr; 8:(4):51-4,
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11995433
HSL7397
Liebman M.
Awakening the Silent Osteoporosis Market
Medical Marketiing and Media 2002 Apr;
http://www.mmm-online.com/content/fileadmin/files/features/2002/Osteo.pdf
HSL1739
Metherell M.
Drug makers told to justify their sky-high prices
Sydney Morning Herald 2002 Mar 30
http://www.smh.com.au/articles/2002/03/29/1017206153767.html
HSL1740
Gordon C.
TV drug ads are tough to swallow
The Ottawa Citizen 2002 Mar 30
HSL1735
Top-Selling Drugs Push Drug Spending Up 17.1% in 2001
2002 Mar 29
Page 133 of 144 pages ‹ First < 131 132 133 134 135 > Last ›
